Medable, Inc

New capabilities. New measures. New possibilities. The next era has arrived ?? ??! This is progress… This is Medable ??! ________ Alison Holland, Michelle Longmire, Tim Smith, Andrew Mackinnon, Colin Weller, Pamela Tenaerts, MD, MBA, Cindy Howry, MS, Hady Khoury, Amar Jani, Marc Ginsky, Martin Cook, Deanna Coscia, Tyler Pugsley #clinicaltrials #clinicalresearch #healthcare #digitalhealth

On this?Rare Disease Day, Cindy Howry, MS shares her deeply personal journey with?Ménière's disease, a rare and unpredictable inner ear condition that affects just?0.2% of the U.S. population. From the?long, exhausting road to diagnosis?to the?uncertain path to treatment, her story highlights the unseen struggles faced by so many in the rare disease community. Cindy’s experience fuels her mission at Medable—breaking down barriers to clinical research?so that more patients, regardless of rarity, have access to the treatments they need. Read her full story here. ?? #RareDiseaseDay #Healthcare #PatientCare

Inclusive trials enhance patient trust in medications ??. During SCOPE 2025, Medable's Dr. Pamela Tenaerts, MD, MBA discussed the importance of representation in clinical trials to ensure treatments are effective for diverse populations. Check out the actionable advice for our industry below! ?? ________ Michelle Longmire, Tim Smith, Alison Holland, Cindy Howry, MS, Hady Khoury, Dave Orrico #clinicaltrials #clinicalresearch #healthcare #drugdevelopment

Get to know the people across Medable, united on one mission to get effective therapies to patients faster ??! The newest edition of Medable Stories features Mary Sweeney, RN, MBA, PMP - a powerhouse on our Professional Services Operations team. Find out a few of her aspirations, areas of expertise, & favorite hobbies below ??: ________ #clinicaltrials #clinicalresearch #healthcare #digitalhealth

Representation in clinical trials matters more than ever! ?? At SCOPE 2025, Medable’s CMO, Dr. Pamela Tenaerts, MD, MBA, sat down to discuss a critical topic: ensuring clinical trials reflect the real-world patient population. Diversity in trials isn’t just about inclusion—it’s about trust, access, and better science. ?? Key insights from the conversation: ?? Trials are moving closer to where patients are—think gastric carcinoma studies in Asia and melanoma trials in high sun exposure areas. ?? Expanding research sites beyond hospitals to retail pharmacies and clinical practices is improving access. ?? When trials reflect true patient diversity, trust in medicines grows—for both patients and clinicians. Watch the full interview now to see how the industry is evolving to make trials more inclusive, accessible, and effective: https://lnkd.in/en3xrkGx ________ Michelle Longmire, Tim Smith, Alison Holland, Dave Orrico, Steve Jones #clinicaltrials #clinicalresearch #healthcare #decentralizedtrials

A top-5 global pharma company needed a smarter approach to patient and site engagement in Japan’s unique regulatory and cultural landscape. They turned to Medable—and the results speak for themselves ??: - eCOA go-live & FPI ahead of schedule - 100% first-call resolution - 99% adherence See how Medable helped streamline operations, enhance site support, and accelerate timelines in the summary below! ?? If you'd like to find out more, send this account a DM, and we'll be in touch asap. ?? ________ Michelle Longmire, Tim Smith, Jon McClelland, Alison Holland, Dave Orrico, Pamela Tenaerts, MD, MBA, Steve Jones #clinicaltrials #clinicalresearch #eCOA #healthcare

Let's imagine a new path forward for clinical trial participants... #QOTD

???The Science Behind eCOA: Why It Matters More Than Ever?? Patient-reported outcomes shape the future of clinical trials—but only if they’re captured accurately and scientifically. At Medable,?Cindy Howry, MS, VP of eCOA Science, is ensuring our eCOA technology meets the highest regulatory and scientific standards. From advancing?BYOD adoption?to redefining?data integrity in clinical assessments, Cindy’s work is shaping the next era of evidence-based trials. Read more about her impact and the future of eCOA below! ?? ________ #clinicaltrials #clinicalresearch #healthcare #eCOA #HEOR

??? Driving Automated Workflows & Accelerating Drug Development with AI-Powered Trials - with Dr. Michelle Longmire, CEO of Medable, Inc. Listen to the full podcast episode here: https://lnkd.in/dYs8jjPp The inefficiencies in clinical trials slow down drug development, delaying access to life-saving treatments. Dr. Longmire highlights how AI-driven optimization can accelerate approvals without compromising safety or efficacy on the 'AI in Business' podcast hosted by Emerj Artificial Intelligence Research??. ________ #AI #clinicaltrials #clinicalresearch #healthcare

AI is transforming numerous aspects of clinical trials—but when it comes to eCOA deployment, what matters most? ??? Vote in the poll below and let us know! ?? #ClinicalTrials #AIinResearch #eCOA